Author

D. Hoagland

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

R. G. Gourdie· 2 shared S. Poelzing· 2 shared A. Alvarez-Laviada· 1 shared A. Jiang· 1 shared A. Nurani· 1 shared B. E. Nilsson-Payant· 1 shared B. R. tenOever· 1 shared C. Y. Oh· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

R. G. Gourdie

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Development and Characterization of the Mode-of-Action of Inhibitory and Agonist Peptides Targeting the Voltage-Gated Sodium Channel SCN1B/β1 Subunit

Z. J. Williams, A. Alvarez-Laviada, D. Hoagland, L. J. Jourdan, S. Poelzing, J. Gorelik, R. G. Gourdie

This study identifies novel SCN1B mimetic peptides that can inhibit or promote β1-mediated adhesion, with effects potentially mediated through β1 RIP.

bioRxiv · Oct 19, 2023Cell Biology

Human organ chip-enabled pipeline to rapidly repurpose therapeutics during viral pandemics

L. Si, H. Bai, M. Rodas, W. Cao, C. Y. Oh, A. Jiang, R. Moller, D. Hoagland, K. Oishi, S. Horiuchi, S. Uhl, D. Blanco-Melo, R. A. Albrecht, W.-C. Liu, T. Jordan, , D. E. Ingber

This paper demonstrates the use of human organ chips to rapidly repurpose therapeutics for viral pandemics, identifying amodiaquine as a potential treatment for SARS-CoV-2.

bioRxiv · Apr 13, 2020 · PreprintMicrobiology

Targeting the Cx43 Carboxyl Terminal H2 Domain Preserves Left Ventricular Function Following Ischemia-Reperfusion Injury

J. Jiang, J. A. Palatinus, H. He, J. Iyyathurai, J. L. Jourdan, D. Hoagland, G. Bultynck, Z. Wang, Z. Zhang, K. Schey, S. Poelzing, F. X. McGowan, R. G. Gourdie

This paper identifies that CT1's interaction with Cx43's carboxyl terminal H2 domain, not ZO-1, mediates its protective effects against ischemia-reperfusion injury in the heart.

bioRxiv · Jun 12, 2019 · PreprintCell Biology